Back to Results

A Phase II, randomized, double blind, parallel group,46 weeks dose-finding study of BI 456906 administered once weekly subcutaneously compared with placebo in patients with obesity or overweight

Study

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Anschutz Health and Wellness
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Marc-Andre Cornier,  MD

Marc-Andre Cornier, MD

Study ID

Protocol Number: 21-2824

More information available at ClinicalTrials.gov: NCT04667377

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers